1. Ries LAG EM, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2002, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005., 2005.
2. Epithelial ovarian cancer: second and third line chemotherapy (review);Latorre;Int J Oncol,2002
3. Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer;Dizon;J Clin Oncol,2002
4. Ovarian cancer chemotherapy;Christian;Cancer Treat Rev,2001
5. Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer;Eisen;Br J Cancer,2000